A former Milwaukee-area lab owner has been sentenced to 15 months in prison and ordered to pay $2.2 million in restitution for his role in a kickback scheme.
Category: Channels
Drugmaker recalls blood pressure treatment common in anesthesia
Provepharm issued a recall of its Phenylephrine hydrochloride injection from lot number 24020027 due to the discovery of black particulate matter in a vial. The affected lot, with an expiration date of December 2025, was distributed nationwide to hospi…
GI growth opportunities to boom by 2030
Several gastroenterology leaders joined Becker’s to discuss the biggest opportunities for ASC growth in the next five years.
Protecting the 340B program: A vital step toward a healthier nation
As the new year begins, gyms are crowded, dieticians’ schedules are packed and dental chairs are filled — signs that Americans are embracing their New Year’s resolutions to focus on health. Alongside these personal commitments, many are also facing imp…
The new normal for hospital capacity
Hospital capacity concerns took center stage in late 2022, as health experts’ warning of a “tripledemic” materialized.
3 GI lawsuits in 1 months
Here are three lawsuits Becker’s has covered involving gastrointestinal physicians or procedures since Jan. 1:
9 drugs in shortage
Here are nine new shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists.
Pennsylvania law voids noncompetes when a physician is dismissed
A Pennsylvania law is limiting the use of noncompetes for certain healthcare providers and the situations wherein they are enforceable, Spotlight PA reported Jan. 18.
10 best states for physician to retire
Florida is the best state to retire, according to personal finance site WalletHub’s 2025 ranking.
Pharmacists to CMS: Stocking drugs in negotiation program could hurt businesses
The National Community Pharmacists Association has told CMS that more than 90% of independent pharmacies may choose to stop stocking drugs included in the Medicare Drug Price Negotiation Program due to financial losses that could threaten their viabili…
